Regentis Biomaterials Ltd. (RGNT)

1.30 -0.07 (-5.11%) USD  |  NYAM  |  Nov 04, 15:43
More

Regentis Biomaterials Price to Book Value

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to . Start Trial.
Date Value
November 04, 2026

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Rosetta Genomics Ltd. --
Endonovo Therapeutics, Inc. --
CollPlant Biotechnologies Ltd. 2.055
Sisram Medical Ltd. --
Elbit Medical Technologies Ltd. 0.1187

Price to Book Value Related Metrics

Price 1.30
Earnings Yield -188.7%
Market Cap 9.131M